|
[1]
|
Nielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A.H., Wewer, U.M. and Nielsen, F.C. (1999) A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development. Molecular and Cellular Biology, 19, 1262-1270. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Bell, J.L., Wächter, K., Mühleck, B., Pazaitis, N., Köhn, M., Lederer, M., et al. (2013) Insulin-Like Growth Factor 2 mRNA-Binding Proteins (IGF2BPs): Post-Transcriptional Drivers of Cancer Progression? Cellular and Molecular Life Sciences, 70, 2657-2675. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wächter, K., Köhn, M., Stöhr, N. and Hüttelmaier, S. (2013) Subcellular Localization and RNP Formation of IGF2BPs (IGF2 mRNA-Binding Proteins) Is Modulated by Distinct RNA-Binding Domains. Biological Chemistry, 394, 1077-1090. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Nielsen, J. (2004) Sequential Dimerization of Human Zipcode-Binding Protein IMP1 on RNA: A Cooperative Mechanism Providing RNP Stability. Nucleic Acids Research, 32, 4368-4376. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., et al. (2018) Recognition of RNA N6-Methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation. Nature Cell Biology, 20, 285-295. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lederer, M., Bley, N., Schleifer, C. and Hüttelmaier, S. (2014) The Role of the Oncofetal IGF2 mRNA-Binding Protein 3 (IGF2BP3) in Cancer. Seminars in Cancer Biology, 29, 3-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ren, Z., Zhao, S. and Zou, P. (2025) Deciphering the RNA Landscape of RNA Granules. Biochemistry, 64, 3156-3164. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Du, Q., Zhu, Z. and Pei, D. (2021) The Biological Function of IGF2BPs and Their Role in Tumorigenesis. Investigational New Drugs, 39, 1682-1693. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ryu, Y., Chang, E., Park, H., Cho, S. and An, J. (2025) Proteogenomic Analysis on RNA m6A Modification-Associated Genes Identifies a Distinct Subgroup with High IGF2BPs Expression across Cancer Types. International Journal of Medical Sciences, 22, 3815-3827. [Google Scholar] [CrossRef]
|
|
[10]
|
Dai, N. (2020) The Diverse Functions of IMP2/IGF2BP2 in Metabolism. Trends in Endocrinology & Metabolism, 31, 670-679. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Deng, Y., Zhu, H., Xiao, L., Liu, C., Liu, Y. and Gao, W. (2021) Identification of the Function and Mechanism of m6A Reader IGF2BP2 in Alzheimer’s Disease. Aging, 13, 24086-24100. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Li, X., Guo, W., Wen, Y., Meng, C., Zhang, Q., Chen, H., et al. (2025) Structural Basis for the RNA Binding Properties of Mouse IGF2BP3. Structure, 33, 771-785.e3. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Korn, S.M., Ulshöfer, C.J., Schneider, T. and Schlundt, A. (2021) Structures and Target RNA Preferences of the RNA-Binding Protein Family of IGF2BPs: An Overview. Structure, 29, 787-803. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Peixoto, P., Cartron, P., Serandour, A.A. and Hervouet, E. (2020) From 1957 to Nowadays: A Brief History of Epigenetics. International Journal of Molecular Sciences, 21, Article 7571. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Yang, C., Hu, Y., Zhou, B., Bao, Y., Li, Z., Gong, C., et al. (2020) The Role of m6A Modification in Physiology and Disease. Cell Death & Disease, 11, Article No. 960. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Vasilopoulou, A., Kalafati, E., Drakopoulou, E. and Anagnou, N.P. (2025) m6A mRNA Methylation in Hematopoiesis: The Importance of Writing, Erasing, and Reading. Cells, 14, Article 1388. [Google Scholar] [CrossRef]
|
|
[17]
|
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., et al. (2014) A METTL3-METTL14 Complex Mediates Mammalian Nuclear RNA N6-Adenosine Methylation. Nature Chemical Biology, 10, 93-95. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Yang, Y., Hsu, P.J., Chen, Y. and Yang, Y. (2018) Dynamic Transcriptomic m6A Decoration: Writers, Erasers, Readers and Functions in RNA Metabolism. Cell Research, 28, 616-624. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Müller, S., Glaß, M., Singh, A.K., Haase, J., Bley, N., Fuchs, T., et al. (2019) IGF2BP1 Promotes SRF-Dependent Transcription in Cancer in a m6A-and miRNA-Dependent Manner. Nucleic Acids Research, 47, 375-390. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zhang, L., Wan, Y., Zhang, Z., Jiang, Y., Gu, Z., Ma, X., et al. (2021) IGF2BP1 Overexpression Stabilizes PEG10 mRNA in an m6A-Dependent Manner and Promotes Endometrial Cancer Progression. Theranostics, 11, 1100-1114. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Wu, H., Ding, X., Hu, X., Zhao, Q., Chen, Q., Sun, T., et al. (2022) LINC01021 Maintains Tumorigenicity by Enhancing N6-Methyladenosine Reader IMP2 Dependent Stabilization of MSX1 and JARID2: Implication in Colorectal Cancer. Oncogene, 41, 1959-1973. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Huo, F., Xie, M., Zhu, Z., Zheng, J. and Pei, D. (2022) SHMT2 Promotes the Tumorigenesis of Renal Cell Carcinoma by Regulating the m6A Modification of PPAT. Genomics, 114, Article ID: 110424. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Cheng, Y., Gao, Z., Zhang, T., Wang, Y., Xie, X., Han, G., et al. (2023) Decoding m6A RNA Methylome Identifies PRMT6-Regulated Lipid Transport Promoting AML Stem Cell Maintenance. Cell Stem Cell, 30, 69-85.e7. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Hu, Y., Gong, C., Li, Z., Liu, J., Chen, Y., Huang, Y., et al. (2022) Demethylase ALKBH5 Suppresses Invasion of Gastric Cancer via PKMYT1 m6A Modification. Molecular Cancer, 21, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Su, C., Zhang, Y., Chen, P., Yang, W., Du, J. and Zhang, D. (2022) Methyltransferase-like 3 Induces the Development of Cervical Cancer by Enhancing Insulin-Like Growth Factor 2 mRNA-Binding Proteins 3-Mediated Apoptotic Chromatin Condensation Inducer 1 mRNA Stability. Bioengineered, 13, 7034-7048. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yu, Y., Lv, D., Wang, C., Song, X., Xie, T., Wang, T., et al. (2022) Hsa_circ_0003258 Promotes Prostate Cancer Metastasis by Complexing with IGF2BP3 and Sponging miR-653-5p. Molecular Cancer, 21, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Gu, Y., Niu, S., Wang, Y., Duan, L., Pan, Y., Tong, Z., et al. (2021) DMDRMR-Mediated Regulation of m6A-Modified CDK4 by m6A Reader IGF2BP3 Drives ccRCC Progression. Cancer Research, 81, 923-934. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Cai, M., Liu, H., Shao, C., Li, T., Jin, J., Liang, Y., et al. (2025) Metabolomics and Metabolites in Cancer Diagnosis and Treatment. Molecular Biomedicine, 6, Article No. 109. [Google Scholar] [CrossRef]
|
|
[29]
|
Yang, J., Shay, C., Saba, N.F. and Teng, Y. (2024) Cancer Metabolism and Carcinogenesis. Experimental Hematology & Oncology, 13, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Byun, J. (2023) Tumor Lactic Acid: A Potential Target for Cancer Therapy. Archives of Pharmacal Research, 46, 90-110. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Ananieva, E.A., Powell, J.D. and Hutson, S.M. (2016) Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond. Advances in Nutrition, 7, 798S-805S. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Xiao, Y., Yang, Y., Xiong, H. and Dong, G. (2024) The Implications of FASN in Immune Cell Biology and Related Diseases. Cell Death & Disease, 15, Article No. 88. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Demicco, M., Liu, X., Leithner, K. and Fendt, S. (2024) Metabolic Heterogeneity in Cancer. Nature Metabolism, 6, 18-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Colhado Rodrigues, B.L., Lallo, M.A. and Perez, E.C. (2020) The Controversial Role of Autophagy in Tumor Development: A Systematic Review. Immunological Investigations, 49, 386-396. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Shen, C., Xuan, B., Yan, T., Ma, Y., Xu, P., Tian, X., et al. (2020) m6A-Dependent Glycolysis Enhances Colorectal Cancer Progression. Molecular Cancer, 19, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Weng, H., Huang, F., Yu, Z., Chen, Z., Prince, E., Kang, Y., et al. (2022) The m6A Reader IGF2BP2 Regulates Glutamine Metabolism and Represents a Therapeutic Target in Acute Myeloid Leukemia. Cancer Cell, 40, 1566-1582.e10. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Xu, Y., Zhou, J., Li, L., Yang, W., Zhang, Z., Zhang, K., et al. (2022) FTO-Mediated Autophagy Promotes Progression of Clear Cell Renal Cell Carcinoma via Regulating SIK2 mRNA Stability. International Journal of Biological Sciences, 18, 5943-5962. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wang, Q., Chen, C., Ding, Q., Zhao, Y., Wang, Z., Chen, J., et al. (2020) METTL3-Mediated m6A Modification of HDGF mRNA Promotes Gastric Cancer Progression and Has Prognostic Significance. Gut, 69, 1193-1205. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Jiang, L., Li, Y., He, Y., Wei, D., Yan, L. and Wen, H. (2021) Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer. Frontiers in Oncology, 11, Article 711207. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Hendrix, M.J.C., Seftor, E.A., Seftor, R.E.B., Chao, J., Chien, D. and Chu, Y. (2016) Tumor Cell Vascular Mimicry: Novel Targeting Opportunity in Melanoma. Pharmacology & Therapeutics, 159, 83-92. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Liu, X., He, H., Zhang, F., Hu, X., Bi, F., Li, K., et al. (2022) m6A Methylated EphA2 and VEGFA through IGF2BP2/3 Regulation Promotes Vasculogenic Mimicry in Colorectal Cancer via PI3K/AKT and ERK1/2 Signaling. Cell Death & Disease, 13, Article No. 483. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Wan, W., Ao, X., Chen, Q., Yu, Y., Ao, L., Xing, W., et al. (2022) METTL3/IGF2BP3 Axis Inhibits Tumor Immune Surveillance by Upregulating N6-Methyladenosine Modification of PD-L1 mRNA in Breast Cancer. Molecular Cancer, 21, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Wei, J., Yin, Y., Zhou, J., Chen, H., Peng, J., Yang, J., et al. (2020) METTL3 Potentiates Resistance to Cisplatin through m6A Modification of TFAP2C in Seminoma. Journal of Cellular and Molecular Medicine, 24, 11366-11380. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Li, T., Hu, P., Zuo, Z., Lin, J., Li, X., Wu, Q., et al. (2019) METTL3 Facilitates Tumor Progression via an m6A-IGF2BP2-Dependent Mechanism in Colorectal Carcinoma. Molecular Cancer, 18, Article No. 112. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Li, H., Huang, G., Tu, J., Lv, D., Jin, Q., Chen, J., et al. (2022) METTL14-Mediated Epitranscriptome Modification of MN1 mRNA Promote Tumorigenicity and All-Trans-Retinoic Acid Resistance in Osteosarcoma. eBioMedicine, 82, Article ID: 104142. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Tatekawa, S., Tamari, K., Chijimatsu, R., Konno, M., Motooka, D., Mitsufuji, S., et al. (2022) N6-Methyladenosine Methylation-Regulated Polo-Like Kinase 1 Cell Cycle Homeostasis as a Potential Target of Radiotherapy in Pancreatic Adenocarcinoma. Scientific Reports, 12, Article No. 11074. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Yang, Z.M., Zhao, F.Q., Gu, X.F., Feng, L.X., Xu, M.S., Li, T., et al. (2021) Binding of RNA m6A by IGF2BP3 Triggers Chemo-Resistance of HCT8 Cells Via Upregulation of ABCB1. American Journal of Cancer Research, 11, 1428-1445.
|
|
[48]
|
Tang, Z., Cao, J., Yao, J., Fan, X., Zhao, J., Zhao, M., et al. (2023) KDM1A-Mediated Upregulation of METTL3 Ameliorates Alzheimer’s Disease via Enhancing Autophagic Clearance of P-Tau through m6A-Dependent Regulation of STUB1. Free Radical Biology and Medicine, 195, 343-358. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Miller, C., Ealy, A., Gregory, A., Janarthanam, C., Albers, W., Richardson, G., et al. (2025) Pathological α-Synuclein Dysregulates Epitranscriptomic Writer METTL3 to Drive Neuroinflammation in Microglia. Cell Reports, 44, Article ID: 115618. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Jingrui, W., Haihui, Y., Jinjin, Y. and Le, F. (2025) IGF2BP2 Regulates the Progression of Alzheimer’s Disease through m6A‐Mediated NLRP3 Inflammasome. Immunity, Inflammation and Disease, 13, e70121. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Yu, Z., Huang, L., Xia, Y., Cheng, S., Yang, C., Chen, C., et al. (2022) Analysis of m6A Modification Regulators in the Substantia Nigra and Striatum of MPTP-Induced Parkinson’s Disease Mice. Neuroscience Letters, 791, Article ID: 136907. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Gong, X., Huang, M. and Chen, L. (2024) nrf1 Mitigates Motor Dysfunction and Dopamine Neuron Degeneration in Mice with Parkinson’s Disease by Promoting GLRX m6A Methylation through Upregulation of METTL3 Transcription. CNS Neuroscience & Therapeutics, 30, e14441. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Wang, Q., Xie, S., Yang, K., Guo, Y., Huang, H., Li, S., et al. (2026) Histone Lactylation Contributes to Neuropathic Pain by Facilitating m6A Reader Protein IGF2BP2 Expression in DRG Sensory Neurons. The Journal of Neuroscience, 46, e0365252025. [Google Scholar] [CrossRef]
|
|
[54]
|
Elssaig, E.H., Ahmed‐Abakur, E.H., Alnour, T.M.S., Alsubai, M.A., Ali, A.E., Ullah, M.F., et al. (2025) Significant Association between Genetic Polymorphism of Insulin‐like Growth Factor‐2 mRNA Binding Protein‐2 and Type 2 Diabetes Mellitus: A Population‐Based Case-Control Study. Journal of Clinical Laboratory Analysis, 39, e25147. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Elssaig, E.H., Ahmed-Abakur, E.H., Alnour, T.M.S., Alsubai, M.A. and Yousif, A. (2024) Significant Association between Insulin-Like Growth Factor 2 mRNA-Binding Protein 2, Interleukin-6 Polymorphisms, and Type 2 Diabetes Mellitus. Journal of Research in Medical Sciences, 29, 71. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Yang, R., Wang, X., Zhang, Y., Jin, L., Zhao, K., Chen, J., et al. (2025) Genetic Variations in IGF2BP2 and CAPN10 and Their Interaction with Environmental Factors Increase Gestational Diabetes Mellitus Risk in Chinese Women. Gene, 941, Article ID: 149226. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Rattanapan, Y., Nongwa, K., Supanpong, C., Satsadeedat, C., Sai-ong, T., Kooltheat, N., et al. (2024) Downregulation of miR-25-3p and Its Impact on PTAFR and IGF2BP3 Expression in Type 2 Diabetes Mellitus: Implications for Biomarker Discovery and Disease Pathogenesis. Journal of Clinical Medicine Research, 16, 536-546. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Regué, L., Zhao, L., Ji, F., Wang, H., Avruch, J. and Dai, N. (2021) RNA m6A Reader IMP2/IGF2BP2 Promotes Pancreatic β-Cell Proliferation and Insulin Secretion by Enhancing PDX1 Expression. Molecular Metabolism, 48, Article ID: 101209. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Alvarez-Dominguez, J.R., Winther, S., Hansen, J.B., Lodish, H.F. and Knoll, M. (2022) An Adipose LncRAP2-Igf2bp2 Complex Enhances Adipogenesis and Energy Expenditure by Stabilizing Target mRNAs. iScience, 25, Article ID: 103680. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Luo, S., Sun, Y., Hu, Y. and Xu, Y. (2025) Lactylation-Induced ALKBH5 Targets RNF123 to Worsen Retinal Müller Cell Activation through PKM2-Regulated Glycolysis in Diabetic Retinopathy. Journal of Translational Medicine, 23, Article No. 105. [Google Scholar] [CrossRef]
|
|
[61]
|
Liang, A., Liu, J., Wei, Y., Liao, Y., Wu, F., Ruan, J., et al. (2023) m6A Reader IGF2BP1 Accelerates Apoptosis of High Glucose-Induced Vascular Endothelial Cells in a m6A-HMGB1 Dependent Manner. PeerJ, 11, e14954. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Wang, T., Li, X., Tao, Y., Wang, X., Li, L. and Liu, J. (2024) METTL3-Mediated NDUFB5 m6A Modification Promotes Cell Migration and Mitochondrial Respiration to Promote the Wound Healing of Diabetic Foot Ulcer. Journal of Translational Medicine, 22, Article No. 643. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Jiang, L., Liu, X., Hu, X., Gao, L., Zeng, H., Wang, X., et al. (2022) METTL3-Mediated m6A Modification of TIMP2 mRNA Promotes Podocyte Injury in Diabetic Nephropathy. Molecular Therapy, 30, 1721-1740. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Yao, Q., Chen, Y., Zhang, X., Wang, L., Li, J., Lv, J., et al. (2025) Decoding m6A RNA Methylation in Kidney Disorders: From Molecular Insights to Therapeutic Strategies. Journal of Translational Medicine, 23, Article No. 771. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Jiang, Y., Peng, J., Song, J., He, J., Jiang, M., Wang, J., et al. (2021) Loss of Hilnc Prevents Diet-Induced Hepatic Steatosis through Binding of IGF2BP2. Nature Metabolism, 3, 1569-1584. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Wang, P., Wang, X., He, D. and Zhuang, C. (2023) LncRNA AK142643 Promotes Hepatic Lipid Accumulation by Upregulating CD36 via Interacting with IGF2BP2. Gene, 887, Article ID: 147747. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Lu, Y., Qie, D., Yang, F. and Wu, J. (2023) LncRNA MEG3 Aggravates Adipocyte Inflammation and Insulin Resistance by Targeting IGF2BP2 to Activate TLR4/NF-κB Signaling Pathway. International Immunopharmacology, 121, Article ID: 110467. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Kuai, D., Zhu, S., Shi, H., Yang, R., Liu, T., Liu, H., et al. (2021) Aberrant Expression of m6A mRNA Methylation Regulators in Colorectal Adenoma and Adenocarcinoma. Life Sciences, 273, Article ID: 119258. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Du, J., Ji, H., Ma, S., Jin, J., Mi, S., Hou, K., et al. (2021) m6A Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity and Stemness in Low-Grade Glioma. Briefings in Bioinformatics, 22, bbab013. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Liu, J., Li, Z., Cheang, I., Li, J. and Zhou, C. (2022) RNA-Binding Protein IGF2BP1 Associated with Prognosis and Immunotherapy Response in Lung Adenocarcinoma. Frontiers in Genetics, 13, Article 777399. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Wang, X., Guan, D., Wang, D., Liu, H., Wu, Y., Gong, W., et al. (2021) Genetic Variants in m6A Regulators Are Associated with Gastric Cancer Risk. Archives of Toxicology, 95, 1081-1088. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Hu, X., Peng, W., Zhou, H., Jiang, J., Zhou, X., Huang, D., et al. (2020) IGF2BP2 Regulates DANCR by Serving as an N6-Methyladenosine Reader. Cell Death & Differentiation, 27, 1782-1794. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Lu, S., Han, L., Hu, X., Sun, T., Xu, D., Li, Y., et al. (2021) N6-Methyladenosine Reader IMP2 Stabilizes the ZFAS1/OLA1 Axis and Activates the Warburg Effect: Implication in Colorectal Cancer. Journal of Hematology & Oncology, 14, Article No. 188. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Wang, Y., Lu, J., Wu, Q., Jin, Y., Wang, D., Chen, Y., et al. (2025) Correction: LncRNA LINRIS Stabilizes IGF2BP2 and Promotes the Aerobic Glycolysis in Colorectal Cancer. Molecular Cancer, 24, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Li, Y., Gu, J., Xu, F., Zhu, Q., Chen, Y., Ge, D., et al. (2021) Molecular Characterization, Biological Function, Tumor Microenvironment Association and Clinical Significance of m6A Regulators in Lung Adenocarcinoma. Briefings in Bioinformatics, 22, bbaa225. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Li, Y., Xiao, J., Bai, J., Tian, Y., Qu, Y., Chen, X., et al. (2019) Molecular Characterization and Clinical Relevance of m6A Regulators across 33 Cancer Types. Molecular Cancer, 18, Article No. 137. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Lv, B., Li, L., Liu, M. and Zou, S. (2026) Circular RNAs in Cancer Immunology: Immune Escape, Therapeutic Resistance, and Nanomedicine Synergies. Translational Oncology, 63, Article ID: 102631. [Google Scholar] [CrossRef]
|
|
[78]
|
Cui, J., Zhu, Y., Liu, X., Wang, W., Jiang, X., Xia, Y., et al. (2022) Comprehensive Analysis of N6-Methyladenosine Regulators with the Tumor Immune Landscape and Correlation between the Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 and Programmed Death Ligand 1 in Bladder Cancer. Cancer Cell International, 22, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Tong, Y., Li, S., Shen, L., Yan, L., Zhu, Z. and Hua, Q. (2025) Multi-Omics and Experimental Validation Identify Methylation-Related Genes and METTL16 as Key Regulators in Diabetic Foot Ulcer Pathogenesis. Scientific Reports, 15, Article No. 42334. [Google Scholar] [CrossRef]
|
|
[80]
|
Liao, S., Zhang, L., Shi, L., Hu, H., Gu, Y., Wang, T., et al. (2025) Integrating Bulk and Single-Cell RNA Sequencing Data: Unveiling RNA Methylation and Autophagy-Related Signatures in Chronic Obstructive Pulmonary Disease Patients. Scientific Reports, 15, Article No. 4005. [Google Scholar] [CrossRef] [PubMed]
|